RE: Some not so good news18 Nov 2019 13:21
Hi Pdub, I can in part answer one of those questions (at the risk of exposing myself to attack!). I won't defend his assertion that this is "contributing to a low share price" but I can certainly explain why "most institutions are unable to invest in BMN". By most institutions I believe he means fund managers, and the simple answer there is a regulatory one - funds have to invest in assets consistent with the fund's risk profile. Most funds simply do not invest in AIM companies for this reason. Of course there are actively managed small-cap funds, funds for special situations, and then there are venture capitalists, hedge funds etc, who may be more than happy to support/short BMN.
Ultimately, I think it's actually pretty reasonable to say most institutions can't/won't invest in BMN, as it currently is. As for your requirement for an explanation from a professional or well-researched perspective, I'll pick the professional option given I work at a large investment company myself (think along the lines of Aviva, Legal&General, etc). I hope that helps simmer things down a little!